Drugs / Agri-King Synbiotic
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01304771 Comparator | Dec 2010 → Apr 2011 | influenza | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Agri-King Synbiotic | “Mayo Clinic in conjunction with Agri-King Corporation has developed a novel synbiotic called AKSB (Agri-King Synbiotic)” NCT01304771 ↗ |
| Known as | AKSB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01304771 ↗ |